β-Casomorphin, bovine (7.5×106 mol/day/kg ; i.g.; for 30 days) increases plasma insulin and decreased plasma glucagon of diabetic rats[3].
β-Casomorphin, bovine (7.5×106 mol/day/kg ; i.g.; for 30 days) alters the changes of SOD, GPx, T-AOC, MDA and H2O2 in the kidney of diabetic rats[3].
β-Casomorphin, bovine (7.5×106 mol/day/kg ; i.g.; for 30 days) reduces MDA (significantly) and H2O2 (non-significantly) level in the kidney compared to the diabetic rats[3].
β-Casomorphin, bovine (7.5×106 mol/day/kg ; i.g.; for 30 days) alleviates high glucose-induced decreasement in SOD and GPx activity, increasement in MDA contents in the NRK-52E cells[3].
| Animal Model: | Male Sprague-Dawley (SD) rats (200 g±10 g)[3] |
| Dosage: | 7.5×106 mol/day/kg |
| Administration: | Oral gavage; for 30 days |
| Result: | Increased plasma insulin and decreased plasma glucagon of diabetic rats. |